[Level 1~3 (Strong~Medium Evidence)] [Lifestyle] [Series: Health Reading Worth Your 50s & 60s]
“I want to reduce sugar, but what should I use instead?” — By your 50s and 60s, many of you are thinking this way based on health checkup results and family health patterns. This article is **based on randomized controlled trials (RCTs) and meta-analyses in humans**, and provides a scientifically re-evaluated, up-to-date guide to five sugar alternatives ranked by strength of evidence and safety.
💡 Important preface
This article has been updated based on the latest evidence as of late 2024. Particularly for stevia, maple syrup, and erythritol, new findings challenging traditional recommendations have emerged — please read the detailed sections carefully.
The Foundation: “Total Reduction” Matters More Than “Which Type”
The World Health Organization (WHO) recommends in its 2015 guidelines that free sugars (added sugars, sugars in honey, syrups, and fruit juices) should constitute less than 10%, ideally no more than 5%, of total daily energy intake. For adults, this amounts to approximately 25g per day (about 6 teaspoons).
The American Heart Association (AHA) similarly recommends that added sugar intake not exceed 25g per day (about 6 teaspoons) for adult women and 36g per day (about 9 teaspoons) for adult men.
Which sweetener you choose matters less than how much total sweetener you consume. The top 5 ranking in this article should be read as “sugar replacement candidates” on the foundation of this principle.
Rank #1: Honey (Raw, Single-Flower)
Strengths: Metabolic marker improvement demonstrated in multiple meta-analyses; robust safety data; polyphenol content
A 2022 meta-analysis by Khan et al., published in the journal Nutrition Reviews, is one of the largest systematic reviews to date, integrating 18 randomized controlled trials (RCTs) with 1,105 total participants. When honey was consumed at a median dose of 40g per day for an average of 8 weeks, the following improvements were reported:
- Fasting blood glucose reduction (effect size: -3.6 mg/dL, 95% CI)
- Total cholesterol reduction
- LDL cholesterol and triglyceride reduction
- HDL cholesterol increase
- ALT liver enzyme reduction
GRADE certainty: Low to Moderate. Due to heterogeneity, future RCTs may shift conclusions, but currently honey shows the most reliable effects among the five alternatives.
Important Limitations: These benefits are most prominent with raw, single-flower honey (acacia, robinia, clover, etc.), and effects diminish with commercially heated honey. Raw honey is rare and expensive in Japan, and may be difficult to obtain. Honey contains pollen, enzymes, polyphenols, and trace elements, which may explain the difference from plain sugar.
- Best Uses: Yogurt, toast, herbal tea, homemade salad dressing
- Recommended Amount: About 1 tablespoon (15g) per day as a starting point. Replacement studies (switching from sugar) show higher efficacy than simply adding honey — replacement over addition is recommended
- ⚠️ Absolute Contraindication: Never give honey to infants under 1 year of age. There is a risk of infant botulism, with multiple fatal cases recorded in Japan (warnings from Japan’s Ministry of Health, Labor and Welfare, US CDC, and AAP). If you have grandchildren, please be especially careful.
Rank #2: Maple Syrup (100% Pure, Grade A)
Strengths: 2024 human RCT; 60+ phytochemicals; traditional food source
⚠️ Conflict of Interest Disclosure: Critical Caveat
In 2024, a randomized, double-blind crossover trial by Morissette et al. was published in the Journal of Nutrition. In 42 adults with mild metabolic abnormalities, an 8-week maple syrup replacement trial reported:
- Blood pressure reduction
- Abdominal fat reduction
- Oral glucose tolerance test (OGTT) improvement
Important Limitations:
- Funding Source: The study received direct research funding from the Quebec Maple Syrup Producers Association (PPAQ) and Agricultural Ministry (MAPAQ). Marion Nestle, a prominent nutritional epidemiologist, flagged the study as “Industry-funded study of the week: maple syrup,” highlighting significant conflicts of interest.
- Small Sample Size: n=42 provides moderate statistical reliability. Independent third-party verification RCT is essential.
- GRADE Certainty: Low to Moderate. Industry funding creates risk of selective reporting bias.
Maple syrup contains 60+ unique phytochemicals including quebecol and other unique compounds. Glycemic index is approximately 54 (lower than sugar), with about 260 kcal per 100g.
- Best Uses: Pancakes, yogurt, black tea, salad dressing, simmered dishes
- Recommended Amount: About 1-2 tablespoons (15-30 mL) per day
- Caution: Confirm product label reads “100% Pure Maple Syrup,” “Grade A.” If you have diabetes, consult your physician regarding carbohydrate content. It would be prudent to await independent RCT verification results.
Rank #3: Erythritol (Sugar Alcohol)
Strengths: Near-zero calories; zero GI; practical for home use
Concern: Cardiovascular Risk — Causation Remains Unproven
Erythritol is a sugar alcohol manufactured from corn via fermentation. Approximately 90% is absorbed in the small intestine and excreted unchanged in urine, yielding effectively zero calories. It is 60-80% as sweet as sugar. In Japan, it can be substituted 1:1 for sugar in cooking — a significant practical advantage.
Gastrointestinal Symptoms: Among sugar alcohols, erythritol causes relatively few digestive symptoms (bloating, diarrhea) according to reports.
Cardiovascular Risk Issue:
- Witkowski et al. Nature Medicine 2023: High blood erythritol concentration was associated with a 3-year increase in cardiovascular events (myocardial infarction, stroke). n=3,139 (discovery n=1,157 + validation n=1,982).
- Causation Strength: Very Weak. Data is observational only, not from RCTs. Reverse causality is possible — meaning: metabolic dysfunction (pentose phosphate pathway activation, oxidative stress, inflammation) → increased blood erythritol production AND increased cardiovascular risk, rather than erythritol intake → cardiovascular risk.
- FDA 2024 Assessment: While acknowledging a possible association, the FDA states “causation is not proven; further investigation is needed.”
- Risk at Typical Doses Unclear: The intake quantity needed to reach risk-level blood concentrations is unknown. Real risk at typical cooking amounts (3-5 g/day) is not quantified.
GRADE Certainty: Low. Evidence is observational only, and causal inference strength is weak with multiple limitations.
- Best Uses: Baked goods, coffee, cooking
- Recommended Amount: Seasoning-level use (1-3 teaspoons per day)
- ⚠️ For those with cardiovascular history: Please consult your physician before use. Even for healthy individuals, excessive intake is prudent to avoid.
Rank #4: Oligosaccharides (Fructooligosaccharides & Galactooligosaccharides)
Strengths: Human RCT evidence for constipation relief; FOSHU (Foods for Specified Health Use) approval; gut microbiome improvement demonstrated
Limited Application: Constipation Relief Only
Fructooligosaccharides (FOS) and galactooligosaccharides (GOS) are not broken down by human digestive enzymes and reach the large intestine, where they serve as “prebiotics” — food for beneficial bacteria like Bifidobacterium. Sweetness is 30-60% of sugar.
A 2024 meta-analysis published in Foods integrated 17 RCTs with 713 total participants. Main results:
- Bowel Movement Frequency: Significant increase (MD = 0.8-1.5 movements/week)
- Stool Consistency: Moderate softening (SMD = 0.36)
- Bifidobacterium: Increase reported
- Adverse Events: Mild abdominal bloating and gas (OR = 10.36) prominent in early use
GRADE Certainty: Moderate. Heterogeneity I² = 94-97% is high, meaning effects vary greatly depending on individual microbiota composition and dosage.
Limited Indications: Effective for functional constipation patients. Unnecessary for healthy individuals, and may introduce side effects (gas, bloating).
- Best Uses: Yogurt or coffee addition for constipation relief
- Recommended Amount: FOS 3-8g/day, GOS 2-5g/day. Gradual increase recommended (start at 3-5 g/day)
- Caution: Early use may cause abdominal bloating, gas, or soft stools. Doses exceeding 30g/day increase diarrhea risk significantly. For those with irritable bowel syndrome (IBS) or other bowel disorders, consult a physician before starting.
Rank #5: Stevia (Purified Rebaudioside Glycosides)
Safety: High (long history of regulatory approval)
Efficacy: Weak Evidence / Gut Bacteria Concern: Newly Highlighted
Stevia is a sweetening compound extracted from a South American plant, offering 200-300 times the sweetness of sugar — allowing very small amounts to provide adequate sweetness.
Safety Data: The European Food Safety Authority (EFSA) sets an Acceptable Daily Intake (ADI) of 4 mg per kg body weight per day (240 mg/day for 60 kg adult). Approved in Japan and by the US FDA; traditionally considered to have “the most robust safety data.”
Weak Evidence of Efficacy: No significant effects on blood glucose reduction or lipid improvement have been reported. If the goal is “sugar avoidance,” choosing a zero-calorie option is reasonable, but expecting metabolic benefits would be unfounded.
Gut Bacteria Concern (Emerging Finding):
- Suez et al. Cell 2022: n=120, 2-week RCT. Saccharin and sucralose showed worsened glucose, but stevia showed “minimal impact.” However, microbiome (gut bacterial composition) changes were observed.
- Manchester University 2024 (Counter-Study): n=27, 12-week longer-term RCT. Chronic stevia consumption resulted in “no microbiome composition changes,” partially contradicting the Suez hypothesis.
- Elinav’s Nuanced Position: Elinav, an author of the Cell 2022 study, acknowledges “long-term clinical harm is unproven,” emphasizing that microbiome change ≠ clinical harm.
GRADE Certainty: Low. Efficacy certainty is low, and gut bacterial effects are based on short-term studies only — long-term safety remains unconfirmed.
- Best Uses: Complete sugar replacement in coffee, black tea
- Recommended Amount: Home use unlikely to exceed ADI
- ⚠️ Caution Points:
- WHO’s 2023 guidelines state that “routine long-term use of non-nutritive sweeteners (NNS) for weight management is not recommended.” Expected metabolic benefits are limited.
- Regarding gut bacterial effects, additional long-term RCT data is needed. The 2024 Manchester study is small (n=27); larger, longer-term verification RCTs are essential.
- If you have diabetes or metabolic disease, consult your physician.
Quick Reference by Use Case
| Use Case | First Choice | Second Choice | Note |
|---|---|---|---|
| Blood glucose & lipid management | Honey (raw, single-flower) | Maple Syrup* | *Beware funding bias |
| Coffee & black tea | Stevia | Erythritol* | *Avoid if cardiovascular history |
| Yogurt | Honey (raw, single-flower) | GOS (constipation only) | Replacement recommended |
| Baked goods | Erythritol* | Maple Syrup | *Avoid if cardiovascular history |
| Pancakes & toast | Maple Syrup* | Honey (raw, single-flower) | *Note industry funding |
| Bowel regularity support | GOS, 3-5g/day (gradual increase) | — | Functional constipation only |
Positioning within evidage’s 4-Axis Scoring Framework
When evaluated using evidage’s 4-axis weighted scoring system, the five sweeteners rank as follows:
- Honey (raw): Medium-to-high effect size (glucose/lipid improvement), moderate certainty, difficult implementation (supply constraints), high cost
- Maple Syrup: Medium effect size (estimated), low-to-moderate certainty (funding bias), easy implementation, medium-to-high cost
- Erythritol: Low effect size (no benefit expected), medium safety (cardiovascular risk unproven), easy implementation, low cost
- Oligosaccharides: Medium effect size (constipation only), moderate certainty, easy implementation, low cost
- Stevia: Low effect size, medium safety (gut bacteria concern), easy implementation, low cost
Overall Score: Honey and maple syrup rank highest, but honey’s implementation is limited by supply constraints and cost. Maple’s funding bias is a material concern. Choice should reflect individual use case and health status.
Alignment with Japanese Medical Guidelines
- Japan Diabetes Society: Recommends low-GI food intake; no official ranking of specific sweeteners
- Japan Circulatory Society: No official position on erythritol or other artificial sweeteners
- Assessment: Independent RCT data from Japan is critically scarce. Dependence on overseas research is high.
Summary — Five Key Takeaways
- “Total reduction” matters far more than “which type.” WHO recommendation: ≤25g free sugars daily
- Current Evidence Frontier (end of 2024): Honey ≥ Maple Syrup > Erythritol, Oligosaccharides > Stevia
- Each Sweetener’s Niche: Honey and maple for “metabolic improvement”; oligosaccharides for “constipation relief”; erythritol and stevia for “sugar avoidance” only
- Emerging Concerns: Maple’s industry funding bias, erythritol’s unproven cardiovascular risk, stevia’s long-term microbiome effects unconfirmed
- High Individual Variation: Gut microbiota, genetics, and dietary habits create wide effect differences. Choice must be personalized to your 50s & 60s health profile
📚 Related Pages
- Evaluation Method — How evidage’s 4-Axis Weighted Scoring Works
- Evidence Basics
- Independence Policy
- This Month’s Top 10
⚠️ ⚠️ ⚠️ Important Medical Disclaimer
Please read this before proceeding with this article.
This article is for informational and educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. All decisions regarding sweetener selection, intake amounts, and dietary changes must be made in consultation with your physician — your personal care doctor or specialist — who is familiar with your age, medical history, family history, and current medications. If you have underlying conditions such as diabetes, gout, dyslipidemia, cardiovascular disease, kidney disease, or fatty liver disease, your physician’s guidance takes priority. evidage assumes no liability for any action or judgment made based on this article’s content. Medical guidelines and recommendations are updated over time — always confirm the latest information with your healthcare provider.
- All decisions regarding sweetener selection, intake amounts, and dietary replacement should be made in consultation with your personal physician or specialist, who understands your personal health profile
- Medical guidelines and recommendations are updated continuously. Always verify the latest information with your healthcare provider
- Referenced percentages, citations, and recommended amounts are general trends and may not apply to you individually
- If you have underlying conditions such as diabetes, gout, dyslipidemia, cardiovascular disease, kidney disease, or fatty liver disease, or if you are pregnant or breastfeeding, follow your physician’s guidance
- evidage assumes no liability for any outcome resulting from actions or judgments based on this article
If you experience concerning symptoms or changes in health, seek medical attention promptly, regardless of this article’s content.
References (Latest 2024 Edition)
International Guidelines:
- WHO: Guideline: Sugars Intake for Adults and Children (2015)
- WHO: Use of Non-Sugar Sweeteners Guideline (2023)
- EFSA: Safety of steviol glycosides E960 (2020, 2024)
- FDA: Erythritol and Cardiovascular Event Risk Evaluation (2024)
Human Trials & Meta-Analyses (2022-2024):
- Khan SU et al. “Effect of honey on cardiometabolic risk factors: a systematic review and meta-analysis.” Nutrition Reviews 2022; 81(7):758-773. [18 RCTs, n=1,105]
- Morissette A et al. “Pure maple syrup supplementation improves cardiometabolic health.” Journal of Nutrition 2024. [n=42 RCT, crossover design] ⚠️ Funded by PPAQ
- Suez J et al. “Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance.” Cell 2022; 185(18):3307-3328. [n=120, 2-week RCT]
- Manchester University Study 2024: “Consumption of the Non-Nutritive Sweetener Stevia for 12 Weeks Does Not Alter the Composition of the Human Gut Microbiota.” [n=27, 12-week RCT, direct contradiction to Suez]
- Witkowski et al. “The artificial sweetener erythritol and cardiovascular event risk.” Nature Medicine 2023; 29(3):710-718. [Observational, n=3,139 total] ⚠️ Causation unproven
- FOS/GOS Meta-analysis. Foods 2024 [17 RCTs, n=713, constipation-focused outcomes]
Independent Expert Assessments:
- Marion Nestle. “Industry-funded study of the week: maple syrup.” Food Politics Blog (2024). [COI transparency analysis]
Japanese Guidelines:
- Japan Diabetes Society Clinical Guidelines for Diabetes Management 2024
- Consumer Affairs Agency (CAA) FOSHU Approval Criteria
※ Figures and recommendations in this article are current as of the December 2024 update. Your personal decisions should be based on the latest information from your healthcare provider.
